JPS4896586A - - Google Patents

Info

Publication number
JPS4896586A
JPS4896586A JP48021120A JP2112073A JPS4896586A JP S4896586 A JPS4896586 A JP S4896586A JP 48021120 A JP48021120 A JP 48021120A JP 2112073 A JP2112073 A JP 2112073A JP S4896586 A JPS4896586 A JP S4896586A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP48021120A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4896586A publication Critical patent/JPS4896586A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP48021120A 1972-02-22 1973-02-21 Pending JPS4896586A (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7202278A NL7202278A (OSRAM) 1972-02-22 1972-02-22

Publications (1)

Publication Number Publication Date
JPS4896586A true JPS4896586A (OSRAM) 1973-12-10

Family

ID=19815436

Family Applications (1)

Application Number Title Priority Date Filing Date
JP48021120A Pending JPS4896586A (OSRAM) 1972-02-22 1973-02-21

Country Status (12)

Country Link
US (1) US3853836A (OSRAM)
JP (1) JPS4896586A (OSRAM)
AU (1) AU471298B2 (OSRAM)
BE (1) BE795788A (OSRAM)
CA (1) CA1030953A (OSRAM)
CH (1) CH585192A5 (OSRAM)
DE (1) DE2308362A1 (OSRAM)
FR (1) FR2181759B1 (OSRAM)
GB (1) GB1416271A (OSRAM)
HU (1) HU168890B (OSRAM)
NL (1) NL7202278A (OSRAM)
ZA (1) ZA73839B (OSRAM)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63225396A (ja) * 1987-03-12 1988-09-20 Dai Ichi Seiyaku Co Ltd ペプチド誘導体
JP2007532476A (ja) * 2004-04-08 2007-11-15 アステラス製薬株式会社 化合物ws727713

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7607684A (nl) * 1976-07-12 1978-01-16 Akzo Nv Werkwijze ter bereiding van nieuwe peptiden en peptide-derivaten en de toepassing hiervan.
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system
WO1986003746A1 (en) * 1984-12-14 1986-07-03 La Trobe University Amino acid and peptide inhibitors of human leucocytic elastase
US5462927A (en) * 1985-04-30 1995-10-31 The Administrators Of The Tulane Educational Fund Peptides aiding nerve regeneration
WO1993000922A1 (en) * 1991-07-01 1993-01-21 The Administrators Of The Tulane Educational Fund Peptides aiding nerve regeneration
US7176279B2 (en) * 2000-06-28 2007-02-13 Palatin Technologies, Inc. Cyclic peptide compositions and methods for treatment of sexual dysfunction
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
EP1695703B1 (en) * 2000-08-25 2010-08-11 Research Corporation Technologies, Inc. Anticonvulsant amino acids for the treatment of obsessive-compulsive neurosis
CA2453515A1 (en) * 2001-07-11 2003-01-23 Palatin Technologies, Inc. Linear and cyclic melanocortin receptor-specific peptides
US6974187B2 (en) * 2004-01-28 2005-12-13 Tachi-S Co., Ltd. Vehicle seat structure
AU2005231034B2 (en) * 2004-04-08 2010-04-08 Telsar Pharma Inc. Compound WS727713
WO2011133348A1 (en) 2010-04-21 2011-10-27 Pharmacofore, Inc. Compositions comprising enzyme-cleavable amphetamine prodrugs and inhibitors thereof
US11590209B2 (en) 2020-01-21 2023-02-28 Palatin Technologies, Inc. Use of bremelanotide in patients with controlled hypertension
CA3199184A1 (en) * 2020-11-18 2022-05-27 Felix Lustenberger Mdma prodrugs to assist psychotherapy
MX2023010506A (es) 2021-03-09 2023-09-20 Ensysce Biosciences Inc Composiciones que comprenden profarmacos de escision enzimatica y nafamostat de liberacion controlada y metodos de uso de estos.
CA3230025A1 (en) 2021-09-29 2023-04-06 Lynn Kirkpatrick Enzyme-cleavable methadone prodrugs and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1302396A (fr) * 1961-03-10 1962-08-31 Ciba Geigy Procédés de préparation de nouveaux heptapeptides de formule l-alpha-[mercaptoalcoyl (inférieur)]-alpha-amino-acétyl-l-glutaminyl-l-histidyl-l-phényl alanyl-l-alpha-[amino-alcoyl (inférieur)]-alpha-amino-acétyl-l-tryptophyl glycine
NL278010A (OSRAM) * 1961-05-04 1900-01-01
NL6509727A (OSRAM) * 1965-07-28 1967-01-30
GB1230472A (OSRAM) * 1967-07-10 1971-05-05

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63225396A (ja) * 1987-03-12 1988-09-20 Dai Ichi Seiyaku Co Ltd ペプチド誘導体
JP2007532476A (ja) * 2004-04-08 2007-11-15 アステラス製薬株式会社 化合物ws727713
JP4793265B2 (ja) * 2004-04-08 2011-10-12 アステラス製薬株式会社 化合物ws727713
JP2014040456A (ja) * 2004-04-08 2014-03-06 Telsar Pharma Inc 化合物ws727713

Also Published As

Publication number Publication date
NL7202278A (OSRAM) 1973-08-24
BE795788A (nl) 1973-08-22
US3853836A (en) 1974-12-10
FR2181759B1 (OSRAM) 1976-09-03
GB1416271A (en) 1975-12-03
AU471298B2 (en) 1976-04-15
HU168890B (OSRAM) 1976-08-28
AU5197973A (en) 1974-08-08
ZA73839B (en) 1973-11-28
DE2308362A1 (de) 1973-09-06
FR2181759A1 (OSRAM) 1973-12-07
CA1030953A (en) 1978-05-09
CH585192A5 (OSRAM) 1977-02-28

Similar Documents

Publication Publication Date Title
FR2181759B1 (OSRAM)
FR2192838B1 (OSRAM)
JPS5133905B2 (OSRAM)
JPS4881923A (OSRAM)
JPS4912394U (OSRAM)
JPS548428Y2 (OSRAM)
JPS528247Y2 (OSRAM)
JPS4976001U (OSRAM)
JPS4921550U (OSRAM)
CS154024B1 (OSRAM)
CS153919B1 (OSRAM)
CS154090B1 (OSRAM)
JPS49101260U (OSRAM)
BG17866A1 (OSRAM)
CH563042A5 (OSRAM)
CH568124A5 (OSRAM)
CH568307A5 (OSRAM)
CH559877A5 (OSRAM)
CH576549B5 (OSRAM)
SE374705B (OSRAM)
CH573498A5 (OSRAM)
CH560847A5 (OSRAM)
CH587602A5 (OSRAM)
CH563739A5 (OSRAM)
CH568313A5 (OSRAM)